全文获取类型
收费全文 | 2672篇 |
免费 | 289篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 90篇 |
妇产科学 | 28篇 |
基础医学 | 290篇 |
口腔科学 | 138篇 |
临床医学 | 364篇 |
内科学 | 419篇 |
皮肤病学 | 15篇 |
神经病学 | 175篇 |
特种医学 | 225篇 |
外科学 | 342篇 |
综合类 | 67篇 |
一般理论 | 2篇 |
预防医学 | 365篇 |
眼科学 | 47篇 |
药学 | 213篇 |
中国医学 | 1篇 |
肿瘤学 | 163篇 |
出版年
2021年 | 30篇 |
2020年 | 22篇 |
2019年 | 21篇 |
2018年 | 43篇 |
2016年 | 37篇 |
2015年 | 34篇 |
2014年 | 53篇 |
2013年 | 78篇 |
2012年 | 100篇 |
2011年 | 90篇 |
2010年 | 54篇 |
2009年 | 58篇 |
2008年 | 96篇 |
2007年 | 100篇 |
2006年 | 115篇 |
2005年 | 129篇 |
2004年 | 140篇 |
2003年 | 109篇 |
2002年 | 97篇 |
2001年 | 66篇 |
2000年 | 60篇 |
1999年 | 58篇 |
1998年 | 52篇 |
1997年 | 41篇 |
1996年 | 45篇 |
1995年 | 34篇 |
1994年 | 38篇 |
1993年 | 38篇 |
1992年 | 49篇 |
1991年 | 52篇 |
1990年 | 44篇 |
1989年 | 64篇 |
1988年 | 66篇 |
1987年 | 64篇 |
1986年 | 61篇 |
1985年 | 70篇 |
1984年 | 42篇 |
1983年 | 53篇 |
1982年 | 38篇 |
1981年 | 23篇 |
1979年 | 33篇 |
1978年 | 37篇 |
1977年 | 27篇 |
1976年 | 37篇 |
1975年 | 21篇 |
1974年 | 40篇 |
1973年 | 35篇 |
1972年 | 29篇 |
1971年 | 28篇 |
1969年 | 23篇 |
排序方式: 共有2973条查询结果,搜索用时 31 毫秒
1.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献2.
3.
4.
5.
6.
7.
8.
9.
Marcia W. Swanson P.T. Forrest C. Bennett M.D. Kirkwood K. Shy M.D. Michael F. Whitfield M.D. 《Developmental medicine and child neurology》1992,34(4):321-337
The predictive validity of infant neuromotor evaluation by the Movement Assessment of Infants (MAI) was investigated in low-birthweight infants. Motor performance at four and eight months was examined in relation to neurodevelopmental outcome at 18 months of age. Correlations were equally strong between total MAI risk scores at four and eight months and performance on the Bayley Scales. Muscle tone observations were more discriminating at four months, and automatic reactions and volitional movement were most predictive at eight months. The MAI was highly sensitive to neurodevelopmental abnormality at four and eight months and more sensitive than the Bayley Motor Scale; both assessment tools had lower specificity at eight months. The high false-positive rate is attributed to transient neuromotor abnormalities and immaturity of motor function in low-birthweight infants with normal outcome. 相似文献
10.
R A Hawkins G White N J Bundred J M Dixon W R Miller H J Stewart A P Forrest 《The British journal of surgery》1987,74(11):1009-1013
The prognostic significance of the tumour activities of 2 steroid receptors, those for oestrogen (ER) and for progestogen (PgR), has been studied in 372 patients with breast cancer, in whom follow-up was available for 2-6 years (median 41 months). Of 252 patients with operable disease, 75.8 per cent had ER-positive tumours and 46.4 per cent had PgR-positive tumours, though a small additional fraction (6.3 per cent) had an equivocal PgR assay result. For the 236 patients with unequivocal receptor status, the relationships between disease-free interval or overall survival and receptor activity and other factors were evaluated by univariate and multivariate analyses. The latter revealed that only tumour size, node status, menstrual status and ER status related significantly to both disease-free interval and survival, though adjuvant therapy also related to disease-free interval, and tumour grade related to survival. It is concluded that measurements of PgR activity do not add to the prognostic significance of ER status. 相似文献